Downregulation of transcription factor, Sp1, during cellular senescence
Ji-Eun Oh1, Jung-A Han, Eun Seong Hwang
1Department of Life Science, University of Seoul, Dongdaemungu, Jeonnongdong 90, Seoul 130-743, Republic of Korea.
Abstract:
We found that the protein level of Sp1 transcription factor decreases as normal human fibroblasts undergo replicative aging. Sp1 also undergoes a rapid decrease in the protein level and activity in MCF-7 cells that are induced to a state of cellular senescence. In the cells treated with other DNA damaging chemicals such as actinomycin D and H(2)O(2), the Sp1 level decreased progressively as well. Inhibition of ATM/ATR kinases prevented this downregulation, suggesting that DNA damage signaling is involved in the regulation of the Sp1. This decrease in Sp1 protein level is due to the accelerated proteasomal degradation since a proteasome inhibitor, ALLN, blocked this downregulation. Therefore, the global decrease in gene transcription frequently reported in aging cells and tissues could be attributed at least in part to the decrease in Sp1 level.
Insights
The Sp1 transcription factor decreases during cellular aging and with DNA damage. This reduction is due to accelerated proteasomal degradation, potentially explaining decreased gene transcription in aging cells.
Area of Science:
- Molecular Biology
- Cellular Senescence
- Transcription Factor Regulation
Background:
- Cellular aging and senescence are associated with global changes in gene expression.
- The Sp1 transcription factor plays a crucial role in regulating gene transcription.
- The regulatory mechanisms of Sp1 during aging and DNA damage are not fully understood.
Purpose of the Study:
- To investigate the changes in Sp1 protein levels during replicative aging and induced cellular senescence.
- To determine the role of DNA damage signaling pathways in regulating Sp1 levels.
- To elucidate the mechanism responsible for Sp1 downregulation.
Main Methods:
- Analysis of Sp1 protein levels in normal human fibroblasts undergoing replicative aging.
- Assessment of Sp1 protein and activity in MCF-7 cells induced into senescence.
- Treatment of cells with DNA damaging agents (actinomycin D, H2O2) and proteasome inhibitor (ALLN).
- Inhibition of ATM/ATR kinases to study DNA damage signaling involvement.
Main Results:
- Sp1 protein levels significantly decrease during replicative aging of human fibroblasts.
- Sp1 protein levels and activity rapidly decline in senescent MCF-7 cells.
- Progressive Sp1 downregulation was observed in cells treated with DNA damaging chemicals.
- Inhibition of ATM/ATR kinases prevented Sp1 downregulation, indicating involvement of DNA damage signaling.
- Sp1 decrease is attributed to accelerated proteasomal degradation, as shown by ALLN treatment.
Conclusions:
- The Sp1 transcription factor is downregulated during cellular aging and senescence.
- DNA damage signaling pathways, involving ATM/ATR kinases, regulate Sp1 levels.
- Accelerated proteasomal degradation is the primary mechanism for Sp1 loss in aging cells.
- Decreased Sp1 levels may contribute to the global reduction in gene transcription observed in aging cells and tissues.
Related Concept Videos
Replicative Cell Senescence
Replicative Cell Senescence
Gene Regulation During Sporulation
General Transcription Factors
Master Transcription Regulators
Master Transcription Regulators


